finance.yahoo.com
Oncolytics Biotech(R) Reports 2019 Second Quarter Financial Results and Operational Highlights
SAN DIEGO, CA and CALGARY, AB / ACCESSWIRE / August 13, 2019 / Oncolytics Biotech® Inc. (ONCY)(TSX:ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced its financial results and operational highlights for the quarter ended June 30, 2019. “Oncolytics